Charles Schwab Investment Management Inc. Acquires 11,239 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL)
Charles Schwab Investment Management Inc. raised its position in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 1.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 677,215 shares of the biotechnology company’s stock after buying an additional 11,239 […]
Charles Schwab Investment Management Inc. raised its position in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 1.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 677,215 shares of the biotechnology company’s stock after buying an additional 11,239 […]
